Batchelor J R, Casey T A, Werb A, Gibbs D C, Prasad S S, Lloyd D F, James A
Lancet. 1976 Mar 13;1(7959):551-4. doi: 10.1016/s0140-6736(76)90355-x.
A series of 200 cases of full-thickness corneal allografts have been followed to determine whether HLA and ABO incompatibility influence prognosis of the grafts. 85% of patients with avascular corneas had clear, functioning grafts one year after transplantation. Only 33% of patients with severely vascularised corneas had successful grafts one year after transplantation. A significant association was found between severe vascularisation of the patient's cornea and irreversible graft rejection. In this group of patients, the proportion of grafts functioning was found to be ranked according to the number of HLA antigens shared by graft donor and recipient. Patients receiving grafts matching for 2 HLA antigens showed a failure-rate due to irreversible rejection of 26% at one year, in comparison with 57% and 62% of grafts matching for 1 or 0 HLA antigens respectively. ABO incompatibility or ABO phenotype of the recipient did not influence graft prognosis. The results indicate that patients with severely vascularised corneas should receive HLA-matched corneal grafts. The institution of HLA-typed cornea "banks" for treatment of such patients is advocated.
对200例全层角膜同种异体移植病例进行了随访,以确定HLA和ABO血型不相容性是否会影响移植的预后。85%无血管角膜患者在移植一年后角膜移植片透明且功能良好。只有33%严重血管化角膜患者在移植一年后移植成功。患者角膜严重血管化与不可逆的移植排斥反应之间存在显著关联。在这组患者中,发现移植片功能正常的比例根据移植供体和受体共有的HLA抗原数量排序。接受匹配2个HLA抗原移植的患者,一年时因不可逆排斥导致的失败率为26%,而匹配1个或0个HLA抗原的移植片分别为57%和62%。受体的ABO血型不相容性或ABO表型不影响移植预后。结果表明,严重血管化角膜患者应接受HLA匹配的角膜移植。提倡建立HLA分型的角膜“库”来治疗这类患者。